Women in England are hoping that a new name for a common hormonal condition, together with a proposed yearly health check, will lead to faster diagnosis and better long-term care. The NHS has adopted the term polyendocrine metabolic ovarian syndrome (PMOS) in place of polycystic ovary syndrome (PCOS), and the National Institute for Health and Care Excellence (NICE) has published draft guidance recommending an annual review for women living with the condition, according to BBC reporting.
The condition is thought to affect roughly one in eight women in the UK. The NHS says it can influence hair growth, menstrual cycles, fertility and mood, a description carried in the BBC's coverage.
Why it matters
Advocates argue that the old name narrowed attention to the ovaries and obscured the wider effects of a condition that touches several systems of the body. Supporters of the change say the new wording better reflects how PMOS affects patients overall. The BBC reports that the rename, announced earlier this year, came alongside the recommendation for regular check-ups.
NICE, the body that issues guidance to the NHS in England, set out its draft proposals in July. The watchdog said the annual review is intended to help clinicians track symptoms, treatments and longer-term health risks. Marie Anne Ledingham, a consultant clinical adviser for women's and reproductive health at NICE, said in the BBC's report that a straightforward yearly appointment would be an important move toward giving patients the continuing care and monitoring they require.
The guidance also aims to make care more consistent across the country, raise awareness of the condition and support earlier diagnosis and management. The final version is scheduled for publication on 27 January.
Patients describe years of uncertainty
The BBC spoke to women whose experiences illustrate why campaigners believe the changes are needed. Neelam Heera-Shergill, from Birmingham, was 18 when she learned she had PCOS. She told the BBC she feared at the time that the diagnosis meant she would never become a mother. She said the news was delivered almost in passing, with a remark that having children might be difficult, and she was left to work out the implications on her own.
Around the start of her university years, she began having irregular and very painful periods, along with thinning hair, weight gain and severe tiredness. She recalled making repeated visits to her GP because exhaustion was causing her to miss lectures and resit exams. She said she was told to exercise more and lose weight before the diagnosis eventually came.
She went on to found Cysters, a Birmingham-based charity that works on inequalities in menstrual, maternal and menopausal health. She later had a daughter, which she described as a major and welcome surprise. While she backs the renaming, she cautioned that understanding of the condition was already limited and that the new term will need explaining too. In her view, if the change prompts more open discussion, it will have been worthwhile.
Rochelle Lewis, 31, from Wolverhampton, described a similar struggle. She told the BBC she was bullied as a child over facial hair and tried many ways to remove it. A family friend first suggested PCOS when she was about 16, but when she raised the possibility with her doctor she felt her concerns were dismissed. She was not formally diagnosed until 2025, a process she called frustrating and emotionally draining because she did not feel listened to.
Now the mother of a seven-month-old son, she said patients are often given a diagnosis and then left to manage alone, without ongoing support. The BBC reports that both women's accounts point to the same gap: information and follow-up care after diagnosis.
What the annual review would change
Under the draft proposals, women with PMOS would be offered a scheduled appointment each year rather than being left to seek help only when symptoms worsen. NICE says the review would give clinicians a chance to reassess symptoms, check whether current treatments are working and look at risks that may build over time.
The watchdog frames the measure as a step toward more uniform care, so that patients in different parts of England receive comparable advice and monitoring. It also expects the guidance to spread awareness among health professionals, which could shorten the path from first symptoms to diagnosis.
For campaigners, the combination of a broader name and a standing appointment addresses two problems at once: how the condition is understood and how it is followed up. The BBC's reporting suggests both women see the rename as a starting point rather than a solution, with much still to be done to improve awareness among patients and clinicians alike.
The next milestone is the publication of NICE's final guideline on 27 January, which will confirm whether the annual review becomes standard practice for the NHS.
